{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:09:38Z","timestamp":1792397378936,"version":"4.4.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Although most patients with alcohol-related liver disease (ALD) have a history of prolonged and heavy drinking, there is no clear threshold defining the level of alcohol consumption that leads to ALD. We aimed to evaluate the correlation between average alcohol consumption and the risk of liver disease and to determine the threshold for clinically significant alcohol consumption.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Using the Korean National Health Insurance database, we identified participants who underwent a health-screening program in 2010 and 2011 and retrospectively analyzed their data until 2019. To diagnose and categorize the extracted participants, we used the International Classification of Diseases version 10 and Fatty Liver Index. The primary outcome was to determine the incidence of newly diagnosed liver-related diseases during the observation period and compare the incidence of liver-related diseases among non-drinkers and drinkers based on the amount of alcohol consumption.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 53,006 patients were enrolled and followed-up for a median of 8.4\u2009years, during which 1,509 cases of liver-related diseases occurred. The participants were divided into five groups: no alcohol consumption (<jats:italic>n<\/jats:italic>\u2009=\u200931,359), 1st quartile (<jats:italic>n<\/jats:italic>\u2009=\u20095,242), 2nd quartile (<jats:italic>n<\/jats:italic>\u2009=\u20095,704), 3rd quartile (<jats:italic>n<\/jats:italic>\u2009=\u20095,337), and 4th quartile (<jats:italic>n<\/jats:italic>\u2009=\u20095,364). The corresponding number of glasses of alcohol consumed per week for each quantile (Q1, Q2, Q3, and Q4) was labeled 2.5\u2009\u00b1\u20091.1 standard units (1 standard unit\u2009=\u20098\u2009g alcohol), 5.4\u2009\u00b1\u20091.9 standard units, 11.5\u2009\u00b1\u20093.3 standard units, and 27.9\u2009\u00b1\u200918.2 standard units, respectively. Compared with non-drinkers, the risk of liver-related disease was found to be higher in Q1 drinkers (adjusted hazard ratio [aHR], 1.09; 95% CI, 0.90\u20131.33), Q2 drinkers (aHR, 1. 10; 95% CI, 0.91\u20131.32), Q3 drinkers (aHR, 1.33; 95% CI, 1.11\u20131.59), and Q4 drinkers (aHR, 1.47; 95% CI, 1.24\u20131.75).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We report that our study has shown that drinking more than 11.5\u2009\u00b1\u20093.3 standard units\/week (92\u2009\u00b1\u200926.4\u2009g\/week) significantly increases the risk of developing liver-related diseases. Therefore, as a preventive measure to reduce the risk of developing liver disease, alcohol consumption should be limited beyond traditionally recommended levels.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1290266","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T08:13:29Z","timestamp":1701159209000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Alcohol consumption and the risk of liver disease: a nationwide, population-based study"],"prefix":"10.3389","volume":"10","author":[{"given":"Sang Yi","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkook","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeo Wool","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeongseok","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Hyun","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2018.09.009","article-title":"Introduction: alcohol and alcoholism","volume":"23","author":"Khaderi","year":"2019","journal-title":"Clin Liver Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2796.2009.02082.x","article-title":"The positive and negative health effects of alcohol-and the public health implications","volume":"265","author":"Gr\u00f8nbaek","year":"2009","journal-title":"J Intern Med"},{"key":"ref3","first-page":"155","article-title":"Chronic diseases and conditions related to alcohol use","volume":"35","author":"Shield","year":"2013","journal-title":"Alcohol Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/s1470-2045(21)00279-5","article-title":"Global burden of Cancer in 2020 attributable to alcohol consumption: a population-based study","volume":"22","author":"Rumgay","year":"2021","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4093\/dmj.2012.36.2.108","article-title":"Alcoholism and diabetes mellitus","volume":"36","author":"Kim","year":"2012","journal-title":"Diabetes Metab J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/hypertensionaha.107.104968","article-title":"Alcohol consumption and the risk of hypertension in women and men","volume":"51","author":"Sesso","year":"2008","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"802163","DOI":"10.3389\/fcvm.2022.802163","article-title":"Alcohol consumption and risk of atrial fibrillation: a dose-response Meta-analysis of prospective studies","volume":"9","author":"Zhang","year":"2022","journal-title":"Front cardiovascular med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.3748\/wjg.v12.i46.7421","article-title":"Pathophysiology of alcoholic pancreatitis: an overview","volume":"12","author":"Chowdhury","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/alzrt157","article-title":"Alcohol-related dementia: an update of the evidence","volume":"5","author":"Ridley","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.35946\/arcr.v40.1.01","article-title":"Alcohol use disorder and depressive disorders","volume":"40","author":"McHugh","year":"2019","journal-title":"Alcohol Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e201997","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the burden of chronic liver disease among hospitalized us adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw Open"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cld.2018.09.011","article-title":"Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease","volume":"23","author":"Axley","year":"2019","journal-title":"Clin Liver Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2022.0017","article-title":"Subclinical versus advanced forms of alcohol-related liver disease: need for early detection","volume":"29","author":"G\u00f3mez-Medina","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology (Baltimore, Md)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clinical gastroenterol and hepatology: official clinical practice J Am Gastroenterol Assoc"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biomedicines7040099","article-title":"Global burden of alcohol use disorders and alcohol liver disease","volume":"7","author":"Rehm","year":"2019","journal-title":"Biomedicine"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.3748\/wjg.v29.i17.2551","article-title":"Alcohol-related hepatitis: a review article","volume":"29","author":"Chaudhry","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.3350\/cmh.2022.0393","article-title":"The effects of moderate alcohol consumption on non-alcoholic fatty liver disease","volume":"29","author":"Oh","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4093\/dmj.2022.0193","article-title":"Current trends of big data research using the Korean National Health Information Database","volume":"46","author":"Kim","year":"2022","journal-title":"Diabetes Metab J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","article-title":"Cardiovascular research using the Korean National Health Information Database","volume":"50","author":"Choi","year":"2020","journal-title":"Korean circulation journal"},{"key":"ref21","unstructured":"Nation health insurance data sharing service"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.3350\/cmh.2022.0362","article-title":"Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: current and future developments","volume":"29","author":"Ahn","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e2120382","DOI":"10.1001\/jamanetworkopen.2021.20382","article-title":"Association of the Frequency and Quantity of alcohol consumption with gastrointestinal Cancer","volume":"4","author":"Yoo","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41409-019-0679-x","article-title":"Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians","volume":"55","author":"Gauthier","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3350\/cmh.2021.0188","article-title":"U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases","volume":"28","author":"Lin","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3350\/cmh.2021.0178","article-title":"Kasl clinical practice guidelines: management of nonalcoholic fatty liver disease","volume":"27","author":"Kang","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"Easl clinical practice guidelines: management of alcohol-related liver disease","volume":"69","author":"Thursz","year":"2018","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.3350\/cmh.2022.0336","article-title":"Screening strategy for non-alcoholic fatty liver disease","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jdi.13756","article-title":"Non-alcoholic fatty liver disease and type\u20092 diabetes: an update","volume":"13","author":"Lee","year":"2022","journal-title":"J diabetes investigation"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12876-015-0348-5","article-title":"Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative data","volume":"15","author":"Pang","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgstr.2022.1005729","article-title":"Sex-specific association between alcohol consumption and liver cirrhosis: An updated systematic review and Meta-analysis","volume":"1","author":"Llamosas-Falc\u00f3n","year":"2022","journal-title":"Front gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/hep.31726","article-title":"Administrative coding in electronic health care record-based research of Nafld: an expert panel consensus statement","volume":"74","author":"Hagstr\u00f6m","year":"2021","journal-title":"Hepatology (Baltimore, Md)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.nut.2015.11.013","article-title":"Alcohol consumption and risk of coronary artery disease: a dose-response Meta-analysis of prospective studies","volume":"32","author":"Yang","year":"2016","journal-title":"Nutrition (Burbank, Los Angeles County, Calif)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ejhf.228","article-title":"Alcohol consumption and risk of heart failure: a dose-response Meta-analysis of prospective studies","volume":"17","author":"Larsson","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e223849","DOI":"10.1001\/jamanetworkopen.2022.3849","article-title":"Association of Habitual Alcohol Intake with risk of cardiovascular disease","volume":"5","author":"Biddinger","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/hep.30864","article-title":"Risks of light and moderate alcohol use in fatty liver disease: follow-up of population cohorts","volume":"71","author":"\u00c5berg","year":"2020","journal-title":"Hepatology (Baltimore, Md)"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"154439","DOI":"10.1016\/j.metabol.2020.154439","article-title":"Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus","volume":"115","author":"Blomdahl","year":"2021","journal-title":"Metab Clin Exp"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"792","DOI":"10.5009\/gnl19163","article-title":"Systematic review with Meta-analysis: low-level alcohol consumption and the risk of liver Cancer","volume":"14","author":"Park","year":"2020","journal-title":"Gut Liver"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/10550887.2020.1736757","article-title":"Alcohol use and risk of suicide: a systematic review and Meta-analysis","volume":"38","author":"Amiri","year":"2020","journal-title":"J Addict Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/aje\/kwac037","article-title":"Can cross-sectional studies contribute to causal inference?","volume":"192","author":"Savitz","year":"2023","journal-title":"Depends Am J Epidemiol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.15288\/jsad.2015.76.158","article-title":"Underreporting in alcohol surveys: whose drinking is underestimated?","volume":"76","author":"Livingston","year":"2015","journal-title":"J Stud Alcohol Drugs"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1290266\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T08:13:34Z","timestamp":1701159214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1290266\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":42,"alternative-id":["10.3389\/fmed.2023.1290266"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1290266","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"article-number":"1290266"}}